Hypereosinophilic syndrome and mepolizumab.
Boucher
Robert M
RM
Gilbert-McClain
Lydia
L
Chowdhury
Badrul
B
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004359:Drug Therapy, Combination; D004804:Eosinophils / Q000187:drug effects; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy*; D007958:Leukocyte Count; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; C434107:mepolizumab